A multinational, double-blind trial with a new antidepressant maprotiline (Ludiomil) and amitriptyline.
D000275:Adjustment Disorders / Q000188:drug therapy*; D000328:Adult; D000639:Amitriptyline / Q000494:pharmacology / Q000627:therapeutic use*; D000873:Anthracenes / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D004341:Drug Evaluation; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011437:Propylamines / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013997:Time Factors
D000873:Anthracenes; D011437:Propylamines; D000639:Amitriptyline